Coronavirus

Public information campaigns may potentially boost rates of vaccination.

As much as 2% of vaccine recipients have reported anaphylaxis following their first shot.

Asymptomatic and symptomatic COVID-19 cases among health care personnel were reduced after vaccination despite surge in infected patients.

The agency is expected to make a statement later today on masking recommendations.

The nasal mucosa was seen to be an essential determinant of overall disease trajectory.

The framework could help officials assess the true burden of disease in certain areas.

Use of remdesivir for COVID-19 was associated with longer hospital stays but was not associated with improved mortality, a recent study of 2344 patients at 123 VA hospitals found.

Modeling showed 1 in 4 infected people pass the infection to a family member.

Pfizer and Moderna will include children aged 5-11 years old in ongoing trials to speak toward risk of rare adverse events observed in other young recipients.

The statement includes over 50 societies and organizations, representing millions of workers.

Communities experiencing such health inequity and disparities are more likely to have mistrust in systems that have continuously failed them. Understanding the perspectives of those disproportionately affected is critical to not only address them, but also work to correct and prevent these disparities moving forward.

Not much is known about the relationship between the expression and activity of SPM pathways and COVID-19 disease severity.

The lineage C.37, (Lambda variant), was recently classified as a variant of interest by the World Health Organization (WHO) based on its high circulation rates in South America, and has showed "the ability to escape from neutralizing antibodies elicited by CoronaVac."

Associations found in people under the age of 45 were weaker in patients over that age.

Patients with a history of malnutrition had higher odds of developing severe disease.

A new report, based on data from dialysis centers, suggests the US is far from reaching so-called “herd immunity.”

While a significantly reduced effectiveness was seen with 1 dose, only a small reduction was observed after 2.

Virtual support services were crucial for providing continued care and education.

PLWH should strictly maintain ART therapy and COVID-19 mitigation efforts.

A new study from IAS 2021 suggests persons with HIV hospitalized for COVID-19 do not face worse mortality nor major cardiovascular event risk.

The designation moves the companies' PDUFA date up to January 2022, when BNT162b2 may become the first regulated COVID-19 vaccine.

94% of the participants developed IgG antibodies against the virus 3 weeks after administration.

Truncated ACE2 levels served to discriminate patients infected with SARS-CoV-2 and influenza A.

A large study finds 1 out of 2 patients develop at least one during their hospital stay.

The Johnson & Johnson vaccine showed neutralizing antibody responses against variants of concern.

Life expectancy for Black and Hispanic Americans dropped 2 to 3 times more than that of White Americans during the pandemic, a research letter in JAMA Network Open said.

Before other states adopt randomly-selected payouts for COVID-19 vaccine administration, further research is needed into these lotteries’ effects on potential increases in vaccination rates.

The MOVe-OUT study will continue to the phase 3 portion and evaluate 800 mg of the therapy administered twice daily.

With vaccine uptake slowing, any information that can help is needed to increase administration.

Genetic changes enable SARS-CoV-2 to enter the body, replicate and trigger out-of-control immune responses.